Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARαand T- and B-cell targeting

Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood

(2013) Berit Granum et al.   Journal of Immunotoxicology

Influenza Vaccine Response in Adults Exposed to Perfluorooctanoate and Perfluorooctanesulfonate

(2013) Claire Looker et al.   TOXICOLOGICAL SCIENCES

Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds

(2012) Philippe Grandjean et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs)

(2011) Emanuela Corsini et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs)

(2010) Emanuela Corsini et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor α, but not human PPARα

(2009) Toshiki Nakamura et al.   TOXICOLOGY

Perfluorooctanoic Acid–Induced Immunomodulation in Adult C57BL/6J or C57BL/6N Female Mice

(2008) Jamie C. DeWitt et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Evaluation of the Immune System in Rats and Mice Administered Linear Ammonium Perfluorooctanoate

(2008) Scott E. Loveless et al.   TOXICOLOGICAL SCIENCES

Suppression of Humoral Immunity in Mice following Exposure to Perfluorooctane Sulfonate

(2008) Margie M. Peden-Adams et al.   TOXICOLOGICAL SCIENCES